| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 1 | 1 | 1 2001 BIOESSAYS 23(11):1037-1046
Anderson GR; Stoler DL; Brenner BM
Cancer: the evolved of a destabilized consequence genome | 7 | 0
|
| 2 | 1 | 2 2001 CANCER RESEARCH 61(21):8014-8021
Li B; Goyal J; Dhar S; Dimri G; Evron E; Sukumar S; Wazer DE; Band V
CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression | 3 | 1
|
| 3 | 1 | 3 2001 CANCER RESEARCH 61(23):8375-8380
Yan PS; Chen CM; Shi HD; Rahmatpanah F; Wei SH; Caldwell CW; Huang THM
Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays | 24 | 5
|
| 4 | 1 | 4 2001 CIRCULATING NUCLEIC ACIDS IN PLASMA OR SERUM II 945():1-7
Lo YMD
Circulating nucleic acids in plasma and serum: An overview | 7 | 0
|
| 5 | 2 | 5 2001 CLINICAL CANCER RESEARCH 7(11):3393-3398
Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V
Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer | 7 | 0
|
| 6 | 1 | 6 2001 ENDOCRINE-RELATED CANCER 8(2):115-127
Yang X; Yan L; Davidson NE
DNA methylation in breast cancer | 10 | 3
|
| 7 | 0 | 7 2001 HUMAN MOLECULAR GENETICS 10(7):687-692
Baylin SB; Esteller M; Rountree MR; Bachman KE; Schuebel K; Herman JG
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer | 77 | 77
|
| 8 | 1 | 8 2001 HUMAN MOLECULAR GENETICS 10(26):3001-3007
Esteller M; Fraga MF; Guo MZ; Garcia-Foncillas J; Hedenfalk I; Godwin AK; Trojan J; Vaurs-Barriere C; Bignon YJ; Ramus S; Benitez J; Caldes T; Akiyama Y; Yuasa Y; Launonen V; Canal MJ; Rodriguez R; Capella G; Peinado MA; Borg A; Aaltonen LA; Ponder BA; Baylin SB; Herman JG
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis | 28 | 5
|
| 9 | 1 | 9 2002 ANALYTICAL BIOCHEMISTRY 310(1):72-83
Carlson SA; Casey TA; Wu MT; Hammes BD; Jones BD
A high-throughput genetic system for assessing the inhibition of proteins: identification of antibiotic resistance and virulence targets and their cognate inhibitors in Salmonella | 0 | 0
|
| 10 | 1 | 10 2002 ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 37():225-236
McLaughlin F; LaThangue N
Tumor classification for tailored cancer therapy | 0 | 0
|
| 11 | 2 | 11 2002 ANTICANCER RESEARCH 22(5):2753-2756
Yang QF; Shan L; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakuda K
5-Aza-2 '-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells | 0 | 0
|
| 12 | 1 | 12 2002 BRITISH JOURNAL OF CANCER 86(11):1817-1823
Satoh A; Toyota M; Itoh F; Kikuchi T; Obata T; Sasaki Y; Suzuki H; Yawata A; Kusano M; Fujita M; Hosokawa M; Yanagihara K; Tokino T; Imai K
DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers | 0 | 0
|
| 13 | 3 | 13 2002 CANCER CELL 2(6):485-495
Yamashita K; Upadhyay S; Osada M; Hoque MO; Xiao Y; Mori M; Sato F; Meltzer SJ; Sidransky D
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma | 2 | 0
|
| 14 | 2 | 14 2002 CANCER LETTERS 183(2):205-213
Bharadwaj S; Prasad GL
Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells | 1 | 0
|
| 15 | 1 | 15 2002 CANCER RESEARCH 62(4):961-966
Liang G; Gonzales FA; Jones PA; Orntoft TF; Thykjaer T
Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2 '- deoxycytidine | 11 | 1
|
| 16 | 2 | 16 2002 CANCER RESEARCH 62(11):3214-3220
Shi HD; Yan PS; Chen CM; Rahmatpanah F; Lofton-Day C; Caldwell CW; Huang THM
Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells | 5 | 1
|
| 17 | 2 | 17 2002 CANCER RESEARCH 62(15):4519-4524
Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors | 6 | 0
|
| 18 | 1 | 18 2002 CANCER RESEARCH 62(20):5906-5911
Lusher ME; Lindsey JC; Latif F; Pearson ADJ; Ellison DW; Clifford SC
Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development | 1 | 0
|
| 19 | 1 | 19 2002 CANCER RESEARCH 62(22):6750-6755
Koslowski M; Tureci Z; Bell C; Krause P; Lehr HA; Brunner J; Seitz G; Nestle FO; Huber C; Sahin U
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer | 0 | 0
|
| 20 | 3 | 20 2002 CANCER RESEARCH 62(23):6981-6989
Harding MA; Arden KC; Gildea JW; Gildea JJ; Perlman EJ; Viars C; Theodorescu D
Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling | 0 | 0
|
| 21 | 2 | 21 2002 CARCINOGENESIS 23(7):1103-1109
Ballestar E; Esteller M
The impact of chromatin in human cancer: linking DNA methylation to gene silencing | 2 | 0
|
| 22 | 1 | 22 2002 CARCINOGENESIS 23(10):1713-1720
Nie Y; Liao J; Zhao X; Song YL; Yang GY; Wang LD; Yang CS
Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma | 0 | 0
|
| 23 | 1 | 23 2002 CELL 109(1):113-124
Li QL; Ito K; Sakakura C; Fukamachi H; Inoue K; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y
Causal relationship between the loss of RUNX3 expression and gastric cancer | 30 | 1
|
| 24 | 1 | 24 2002 CHROMOSOMA 111(1):13-21
Marhold J; Zbylut M; Lankenau DH; Li MF; Gerlich D; Ballestar E; Mechler BM; Lyko F
Stage-specific chromosomal association of Drosophila dMBD2/3 during genome activation | 2 | 0
|
| 25 | 2 | 25 2002 CLINICAL CANCER RESEARCH 8(7):2246-2252
Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi HD; Ng SW; Yan PS; Nephew KP; Brown R; Huang THM
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers | 4 | 0
|
| 26 | 1 | 26 2002 CLINICAL CANCER RESEARCH 8(10):3164-3171
Ogi K; Toyota M; Ohe-Toyota M; Tanaka N; Noguchi M; Sonoda T; Kohama G; Tokino T
Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma | 1 | 0
|
| 27 | 1 | 27 2002 CURRENT OPINION IN BIOTECHNOLOGY 13(5):473-481
Kren BT; Steer CJ
The application of DNA repair vectors to gene therapy | 0 | 0
|
| 28 | 1 | 28 2002 ENVIRONMENTAL HEALTH PERSPECTIVES 110():827-830
Jacob ST; Majumder S; Ghoshal K
Suppression of metallothionein-I/II expression and its probable molecular mechanisms | 0 | 0
|
| 29 | 1 | 29 2002 GASTROENTEROLOGY CLINICS OF NORTH AMERICA 31(2):379-+
Katz JP; Kaestner KH
Cellular and molecular mechanisms of carcinogenesis | 0 | 0
|
| 30 | 1 | 30 2002 GENES CHROMOSOMES & CANCER 34(4):398-405
Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA
No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors | 1 | 0
|
| 31 | 1 | 31 2002 GENES CHROMOSOMES & CANCER 35(1):58-65
Schulz WA; Elo JP; Florl AR; Pennanen S; Santourlidis S; Engers R; Buchardt M; Seifert HH; Visakorpi T
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma | 1 | 0
|
| 32 | 3 | 32 2002 GENOME RESEARCH 12(10):1591-1598
Dai ZY; Weichenhan D; Wu YZ; Hall JL; Rush LJ; Smith LT; Raval A; Yu L; Kroll D; Muehlisch J; Fruhwald MC; de Jong P; Catanese J; Davuluri RV; Smiraglia DJ; Plass C
An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands | 1 | 0
|
| 33 | 1 | 33 2002 GENOME RESEARCH 12(12):1860-1870
Yatsuki H; Joh K; Higashimoto K; Soejima H; Arai Y; Wang YD; Hatada I; Obata Y; Morisaki H; Zhang ZM; Nakagawachi T; Satoh Y; Mukai T
Domain regulation of imprinting cluster in Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: Large-scale DNA methylation analysis reveals that DMR-Lit1 is control region | 1 | 0
|
| 34 | 1 | 34 2002 GENOMICS 79(3):363-375
Tomatsu S; Orii KO; Islam MR; Shah GN; Grubb JH; Sukegawa K; Suzuki Y; Orii T; Kondo N; Sly WS
Methylation patterns of the human beta-glucuronidase gene locus: Boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides | 0 | 0
|
| 35 | 1 | 35 2002 GENOMICS 80(6):621-629
Jiang CL; Jin SG; Lee DH; Lan ZJ; Xu XP; O'Connor TR; Szabo PE; Mann JR; Cooney AJ; Pfeifer GP
MBD3L1 and MBD3L2, two new proteins homologous to the methyl- CpG-binding proteins MBD2 and MBD3: Characterization of MBD3L1 as a testis-specific transcriptional repressor | 0 | 0
|
| 36 | 1 | 36 2002 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 16(4):775-+
Lynch JP; Hoops TC
The genetic pathogenesis of colorectal cancer | 0 | 0
|
| 37 | 1 | 37 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(18):16048-16058
Majumder S; Ghoshal K; Datta J; Bai SM; Dong XC; Quan N; Plass C; Jacob ST
Role of de novo DNA Methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma | 2 | 0
|
| 38 | 1 | 38 2002 JOURNAL OF DRUG TARGETING 10(2):133-141
Richardson P; Thoma C; Kren BT; Steer CJ
Strategies for hepatic gene correction | 0 | 0
|
| 39 | 1 | 39 2002 JOURNAL OF GASTROENTEROLOGY 37(1):73-74
Toyota M; Itoh F; Imai K
Can DNA methylation be a molecular marker for eradication of Helicobactor pylori in MALT lymphoma? | 0 | 0
|
| 40 | 1 | 40 2002 JOURNAL OF GASTROENTEROLOGY 37():97-101
Toyota M; Itoh F; Kikuchi T; Satoh A; Obata T; Suzuki H; Ishii S; Endo T; Tokino T; Imai K
DNA methylation changes in gastrointestinal disease | 0 | 0
|
| 41 | 1 | 41 2002 JOURNAL OF HUMAN GENETICS 47(9):460-464
Janssen JWG; Imoto I; Inoue J; Shimada Y; Ueda M; Imamura M; Bartram CR; Inazawa J
MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas | 0 | 0
|
| 42 | 1 | 42 2002 JOURNAL OF PATHOLOGY 196(1):1-7
Esteller M; Herman JG
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours | 31 | 1
|
| 43 | 1 | 43 2002 JOURNAL OF THE NATIONAL CANCER INSTITUTE 94(7):504-513
Yu XD; Guo ZS; Marcu MG; Neckers L; Nguyen DM; Chen GA; Schrump DS
Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228 | 5 | 0
|
| 44 | 1 | 44 2002 LIVER TRANSPLANTATION 8(12):1089-1108
Kren BT; Chowdhury NR; Chowdhury JR; Steer CJ
Gene therapy as an alternative to liver transplantation | 0 | 0
|
| 45 | 1 | 45 2002 METHODS 27(2):114-120
Rand K; Qu WJ; Ho T; Clark SJ; Molloy P
Conversion-specific detection of DNA methylation using real- time polymerase chain reaction (ConLight-MSP) to avoid false positives | 1 | 0
|
| 46 | 2 | 46 2002 METHODS 27(2):170-178
Siegmund KD; Laird PW
Analysis of complex methylation data | 1 | 0
|
| 47 | 1 | 47 2002 MOLECULAR AND CELLULAR BIOLOGY 22(9):3157-3173
Curradi M; Izzo A; Badaracco G; Landsberger N
Molecular mechanisms of gene silencing mediated by DNA methylation | 6 | 1
|
| 48 | 2 | 48 2002 MOLECULAR AND CELLULAR BIOLOGY 22(23):8302-8319
Ghoshal K; Datta J; Majumder S; Bai SM; Dong XC; Parthun M; Jacob ST
Inhibitors of histone deacetylase and DNA methyltransfcrase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure | 1 | 0
|
| 49 | 1 | 49 2002 MOLECULAR BIOLOGY 36(5):625-630
Babenko OV; Zemlyakova VV; Saakyan SV; Brovkina AF; Strelnikov VV; Zaletaev DV; Nemtsova MV
RB1 and CDKN2A functional defects resulting in retinoblastoma | 0 | 0
|
| 50 | 1 | 50 2002 MOLECULAR CARCINOGENESIS 35(2):93-102
Tao LH; Li YZ; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA
Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors | 1 | 0
|
| 51 | 1 | 51 2002 MOLECULAR GENETICS AND METABOLISM 75(1):1-16
Fruhwald MC; Plass C
Global and gene-specific methylation patterns in cancer: Aspects of tumor biology and clinical potential | 3 | 2
|
| 52 | 1 | 52 2002 NUCLEIC ACIDS RESEARCH 30(8):1713-1724
Braastad CD; Leguia M; Hendrickson EA
Ku86 autoantigen related protein-1 transcription initiates from a CpG island and is induced by p53 through a nearby p53 response element | 2 | 0
|
| 53 | 1 | 53 2002 ONCOGENE 21(7):1048-1061
Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ
Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells | 7 | 2
|
| 54 | 1 | 54 2002 ONCOGENE 21(17):2741-2749
Kikuchi T; Toyota M; Itoh F; Suzuki H; Obata T; Yamamoto H; Kakiuchi H; Kusano M; Issa JPJ; Tokino T; Imai K
Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors | 2 | 0
|
| 55 | 1 | 55 2002 ONCOGENE 21(24):3909-3916
Smiraglia DJ; Szymanska J; Kraggerud SM; Lothe RA; Peltomaki P; Plass C
Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors | 4 | 1
|
| 56 | 1 | 56 2002 ONCOGENE 21(27):4340-4344
Toyooka S; Carbone M; Toyooka K; Bocchetta M; Shivapurkar N; Minna JD; Gazdar AF
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells | 2 | 0
|
| 57 | 1 | 57 2002 ONCOGENE 21(35):5361-5379
Robertson KD
DNA methylation and chromatin - unraveling the tangled web | 4 | 1
|
| 58 | 2 | 58 2002 ONCOGENE 21(35):5380-5387
Clark SJ; Melki J
DNA methylation and gene silencing in cancer: which is the guilty party? | 1 | 1
|
| 59 | 1 | 59 2002 ONCOGENE 21(35):5388-5393
Turker MS
Gene silencing in mammalian cells and the spread of DNA methylation | 3 | 0
|
| 60 | 3 | 60 2002 ONCOGENE 21(35):5414-5426
Smiraglia DJ; Plass C
The study of aberrant methylation in cancer via restriction landmark genomic scanning | 2 | 1
|
| 61 | 3 | 61 2002 ONCOGENE 21(35):5427-5440
Esteller M
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future | 4 | 0
|
| 62 | 1 | 62 2002 ONCOGENE 21(35):5450-5461
Tsou JA; Hagen JA; Carpenter CL; Laird-Offringa IA
DNA methylation analysis: a powerful new tool for lung cancer diagnosis | 0 | 0
|
| 63 | 2 | 63 2002 ONCOGENE 21(35):5483-5495
Christman JK
5-Azacytidine and 5-aza-2 '-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy | 2 | 0
|
| 64 | 1 | 64 2002 ONCOGENE 21(45):6949-6959
McWilliams A; MacAulay C; Gazdar AF; Lam S
Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions | 0 | 0
|
| 65 | 1 | 65 2002 ONCOGENE 21(48):7298-7306
Wistuba II; Mao L; Gazdar AF
Smoking molecular damage in bronchial epithelium | 1 | 0
|
| 66 | 1 | 66 2002 ONCOGENE 21(58):9033-9042
Mukai T; Sekiguchi M
Gene silencing in phenomena related to DNA repair | 0 | 0
|
| 67 | 1 | 67 2002 ONCOLOGIST 7(5):451-457
Zochbauer-Muller S; Minna JD; Gazdar AF
Aberrant DNA methylation in lung cancer: Biological and clinical implications | 0 | 0
|
| 68 | 1 | 68 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(15):10060-10065
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis | 2 | 0
|
| 69 | 1 | 69 2002 SEMINARS IN CANCER BIOLOGY 12(5):347-357
Melki JR; Clark SJ
DNA methylation changes in leukaemia | 0 | 0
|
| 70 | 4 | 70 2002 SEMINARS IN CANCER BIOLOGY 12(5):359-371
Catteau A; Morris JR
BRCA1 methylation: a significant role in tumour development? | 2 | 0
|
| 71 | 2 | 71 2003 BIOCHEMICAL PHARMACOLOGY 65(2):219-225
Wyczechowska D; Fabianowska-Majewska K
The effects of cladribine and fludarabine on DNA methylation in K562 cells | 0 | 0
|
| 72 | 1 | 72 2003 BLOOD 101(7):2784-2788
Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma | 0 | 0
|
| 73 | 1 | 73 2003 INTERNATIONAL JOURNAL OF CANCER 104(5):568-578
Kimura F; Seifert HH; Florl AR; Santourlidis S; Steinhoff C; Swiatkowski S; Mahotka C; Gerharz CD; Schulz WA
Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma | 0 | 0
|
| 74 | 1 | 74 2003 JOURNAL OF CELLULAR BIOCHEMISTRY 88(5):885-898
Shivapurkar N; Reddy J; Chaudhary PM; Gazdar AF
Apoptosis and lung cancer: A review | 0 | 0
|
| 75 | 2 | 75 2003 MOLECULAR AND CELLULAR BIOLOGY 23(8):2709-2719
Liu K; Wang YF; Cantemir C; Muller MT
Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo | 0 | 0
|
| 76 | 2 | 76 2003 ONCOGENE 22(2):274-280
Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
Methylation-associated silencing of heparan sulfate D- glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers | 0 | 0
|
| 77 | 1 | 77 2003 ONCOGENE 22(6):924-934
Chan AOO; Kim SG; Bedeir A; Issa JP; Hamilton SR; Rashid A
CpG island methylation in carcinoid and pancreatic endocrine tumors | 0 | 0
|
| 78 | 1 | 78 2003 ONCOGENE 22(11):1668-1677
Nasr AF; Nutini M; Palombo B; Guerra E; Alberti S
Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene | 0 | 0
|